Simvastatin attenuates hypomyelination induced by hypoxia-ischemia in neonatal rats

Neurological Research

Volumn 32, Issue 9, 2010, Pages 945-952

  Li, Aiping ^a   Lv, Shuhong ^a   Yu, Zhe ^a   Zhang, Yumei ^a   Ma, Hui ^a   Zhao, Hui ^a   Piao, Hua ^a   Li, Shao ^a   Zhang, Nannan ^a   Sun, Changkai ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hypomyelination; Hypoxic ischemic brain damage; Microglia; Neonatal rats; Simvastatin

Indexed keywords

BRAIN PROTEIN; MYELIN BASIC PROTEIN; PROTEIN OX 42; SIMVASTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL COUNT; CELL LOSS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GRAY MATTER; HYPOMYELINATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MYELINATION; NISSL STAINING; NONHUMAN; OLIGODENDROGLIA; RAT; SPRAGUE DAWLEY RAT; WHITE MATTER;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD11B; BODY WEIGHT; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOXIA-ISCHEMIA, BRAIN; MYELIN BASIC PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN;

EID: 77957583421     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164110X12670144737774     Document Type: Article

References (39)

1. Calvert JW, Zhang JH. Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol Res. 2005; 27: 246-60.
2. Ferriero DM. Neonatal brain injury. N Engl J Med. 2004; 351: 1985-95.
3. Goldberg MP, RansomBR. New light on white matter. Stroke. 2003; 34: 330-32.
4. Back SA. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechan-isms. Ment Retard Dev Disabil Res Rev. 2006; 12: 129-40.
5. Back SA, Craig A, Luo NL, Ren J, Akundi RS, Ribeiro I, et al. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann Neurol. 2006; 60: 696-705.
6. Kaur C, Ling EA. Periventricular white matter damage in the hypoxic neonatal brain: role ofmicroglial cells. Prog Neurobiol. 2009; 87: 264-80.
7. Feldhaus B, Dietzel ID, Heumann R, Berger R. Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. J Soc Gynecol Investig. 2004; 11: 89-96.
8. Du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol. 2002; 15: 151-57.
9. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci. 2002; 22: 455-63.
10. Biran V, Joly LM, Héron A, Vernet A, Vega C, Mariani J, et al. Glial activation in white matter following ischemia in the neonatal P7 rat brain. Exp Neurol. 2006; 199: 103-12.
11. Zhang SC, Goetz BD, Duncan ID. Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors. Glia. 2003, 41: 191-198.
12. Cai Z, Lin S, Pang Y, Rhodes PG. Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatr Res. 2004; 56: 377-84.
13. Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci. 2003; 23: 11104-11.
14. Veillard NR, Mach F. Statins: the new aspirin? Cell Mol Life Sci. 2002; 59: 1771-86.
15. Miron VE, Rajasekharan S, Jarjour AA, Zamvil SS, Kennedy TE, Antel JP. Simvastatin regulates oligodendroglial process dynamics and survival. Glia. 2007; 55: 130-43.
16. Holmberg E, Nordstrom T, Gross M, Kluge B, Zhang SX, Doolen S. Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury. J Neurotrauma. 2006; 23: 1366-78.
17. Balduini W, Mazzoni E, Carloni S, de Simoni MG, Perego C, Sironi L, et al. Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and mor-phological consequences of neonatal HI brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke. 2003; 34: 2007-12.
18. van der Most PJ, Dolga AM, Nijholt IM, Luiten PG, Eisel UL. Statin: mechanism of neuroprotection. Prog Neurobiol 2009; 88: 64-75.
19. Vaughan CJ. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol. 2003; 9: 23B-29B.
20. Ovbiagele B. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005; 36: 2344.
21. Nagaraja TN, Knight RA, Croxen RL, Konda KP, Fenstermacher JD. Acute neurovascular unit protection by simvastatin in transient cerebral ischemia. Neurol Res. 2006; 28: 826-30.
22. Shabanzadeh AP, Shuaib A, Wang CX. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res. 2005; 1042: 1-5.
23. Carloni S, Mazzoni E, Cimino M, de Simoni MG, Perego C, Scopa C, et al. Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat. Neurobiol Dis. 2006; 21: 119-26.
24. Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981; 9: 131-41.
25. Leviton A, Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 2007; 30: 473-78.
26. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci. 2000; 20: 9235-41.
27. Dalmau I, Vela JM, González B, Finsen B, Castellano B. Dynamics of microglia in the developing rat brain. J Comp Neurol 2003; 458: 144-57.
28. Dalmau I, Vela JM, González B, Castellano B. Expression of purine metabolism-related enzymes by microglial cells in the developing rat brain. J Comp Neurol. 1998; 398: 333-46.
29. Ponce J, de la Ossa NP, Hurtado O, Millan M, Arenillas JF, Dávalos A, et al. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke. 2008; 39: 1269-75.
30. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001; 81: 871-910.
31. Simons M, Trajkovic K. Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J Cell Sci. 2006; 119: 4381-89.
32. Dietschy JM, Turley SD. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004; 45: 1375-97.
33. Lechpammer M, Manning SM, Samonte F, Nelligan J, Sabo E, Talos DM. Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathol Appl Neurobiol. 2008; 34: 379-93.
34. Clarke RM, O'Connell F, Lyons A, Lynch MA. The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration ofamyloid-beta1-42 in the rat hippocam-pus in vivo. Neuropharmacology. 2007; 52: 136-45.
35. Nakamichi K, Saiki M, Kitani H, Kuboyama Y, Morimoto K, Takayama-Ito M, et al. Suppressive effect of simvastatin on interferon-beta-induced expression of CC chemokine ligand 5 in microglia. Neurosci Lett. 2006; 407: 205-10.
36. Paintlia AS, Paintlia MK, Khan M, Vollmer T, Singh AK, Singh I. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model ofmultiple sclerosis. FASEB J. 2005; 19: 1407-21.
37. Klopfleisch S, Merkler D, Schmitz M, Kloppner S, Schedensack M, Jeserich G, et al. Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. J Neurosci. 2008; 28: 13609-14.
38. Miron VE, Zehntner SP, Kuhlmann T, Ludwin SK, Owens T, Kennedy TE, et al. Statin therapy inhibits remyelination in the central nervous system. Am J Pathol. 2009; 174: 1880-90.
39. Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, et al. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther. 2005; 312: 786-93.